INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, vol.75, 2021 (SCI-Expanded)
Background Mast cells play a critical role in cancer-associated immunity. We aimed to determine the predictive value of urinary mast cell mediators in patients with non-muscle invasive bladder cancer (NMIBC) treated with Bacillus Calmette-Guerin (BCG) immunotherapy.